Software Development Engineer Co-op (Jan- Aug)
Boston Scientific5 days ago
Waltham, MA, USAIntern
Base Salary
$45k - $76k/yr
Responsibilities
- Design, develop, and unit test software applications using C++ in a Linux environment.
- Participate in Agile scrum teams to develop features and resolve technical issues.
- Collaborate with software development, testing, and cross-functional teams throughout the development lifecycle.
- Contribute to user interface, algorithm development, and backend data handling components.
- Apply problem-solving skills to deliver reliable software solutions.
- Develop technical capabilities through mentorship and hands-on experience.
Requirements
- Currently pursuing a bachelor’s or graduate-level degree majoring in Computer Science or Biomedical Engineering and Electrical Engineering, with an expected graduation date in fall/winter 2027 or spring 2030.
- Programming proficiency in C, C++, or Rust and a strong understanding of object-oriented programming principles.
- Available for the full co-op duration from January 11 through August 6 or August 13, 2027.
- Eligible to work in the U.S. without company sponsorship, now or in the future, for employment-based work authorization.
- Preferred qualifications include systems-level programming, Linux, Qt, technical documentation, report writing, strong communication, attention to detail, adaptability, and the ability to work independently and collaboratively.
- Must have reliable transportation to and from the Waltham, Massachusetts office.
Benefits
- Hybrid work model requiring at least four days per week in the local office.
- Relocation assistance may be available to eligible participants.
- Co-op duration runs from January 11 through August 6 or August 13, 2027.
- Boston Scientific does not provide transportation or transportation support to and from the office.
About Boston Scientific
Boston Scientific designs and manufactures implantable and minimally invasive medical devices used by physicians to diagnose and treat cardiovascular, endoscopic, urological, neurological, and other conditions. It sells these products and related therapies to hospitals and health systems worldwide through a direct sales model and distributors. Founded in 1979 and headquartered in Marlborough, Massachusetts, it is publicly traded on the NYSE (BSX) with offerings spanning stents, catheters, electrophysiology, and neuromodulation systems.